Literature DB >> 11884425

A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation.

Chyi-Song Hsieh1, Paul deRoos, Karen Honey, Courtney Beers, Alexander Y Rudensky.   

Abstract

The enzymes that degrade proteins to peptides for presentation on MHC class II molecules are poorly understood. The cysteinal lysosomal proteases, cathepsin L (CL) and cathepsin S (CS), have been shown to process invariant chain, thereby facilitating MHC class II maturation. However, their role in Ag processing is not established. To examine this issue, we generated embryonic fibroblast lines that express CL, CS, or neither. Expression of CL or CS mediates efficient degradation of invariant chain as expected. Ag presentation was evaluated using T cell hybridoma assays as well as mass spectroscopic analysis of peptides eluted from MHC class II molecules. Interestingly, we found that the majority of peptides are presented regardless of CL or CS expression, although these proteases often alter the relative levels of the peptides. However, for a subset of Ags, epitope generation is critically regulated by CL or CS. This result suggests that these cysteinal proteases participate in Ag processing and generate qualitative and quantitative differences in the peptide repertoires displayed by MHC class II molecules.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884425     DOI: 10.4049/jimmunol.168.6.2618

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

Review 1.  Specialized roles for cysteine cathepsins in health and disease.

Authors:  Jochen Reiser; Brian Adair; Thomas Reinheckel
Journal:  J Clin Invest       Date:  2010-10-01       Impact factor: 14.808

Review 2.  Immunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseases.

Authors:  Sun Jung Kim
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 3.  Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents.

Authors:  Melisa Bunderson-Schelvan; Andrij Holian; Raymond F Hamilton
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017       Impact factor: 6.393

4.  Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.

Authors:  Sanja Sever; Mehmet M Altintas; Sharif R Nankoe; Clemens C Möller; David Ko; Changli Wei; Joel Henderson; Elizabetta C del Re; Lianne Hsing; Ann Erickson; Clemens D Cohen; Matthias Kretzler; Dontscho Kerjaschki; Alexander Rudensky; Boris Nikolic; Jochen Reiser
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

5.  Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sites.

Authors:  Bin Yu; Dora P A J Fonseca; Sara M O'Rourke; Phillip W Berman
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

6.  Regulation of HLA-DR peptide occupancy by histone deacetylase inhibitors.

Authors:  Kevin Cronin; Hernando Escobar; Karoly Szekeres; Eduardo Reyes-Vargas; Alan L Rockwood; Mark C Lloyd; Julio C Delgado; George Blanck
Journal:  Hum Vaccin Immunother       Date:  2013-01-17       Impact factor: 3.452

7.  Cathepsin L is essential for onset of autoimmune diabetes in NOD mice.

Authors:  René Maehr; Justine D Mintern; Ann E Herman; Ana-Maria Lennon-Duménil; Diane Mathis; Christophe Benoist; Hidde L Ploegh
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

Review 8.  Hepatitis C virus and ethanol alter antigen presentation in liver cells.

Authors:  Natalia A Osna
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

9.  Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity.

Authors:  Blake F Frey; Jiansheng Jiang; Yongjun Sui; Lisa F Boyd; Bin Yu; Gwen Tatsuno; Rolf Billeskov; Shahram Solaymani-Mohammadi; Phillip W Berman; David H Margulies; Jay A Berzofsky
Journal:  J Immunol       Date:  2018-01-26       Impact factor: 5.422

10.  Induction of an antitumor response using dendritic cells transfected with DNA constructs encoding the HLA-A*02:01-restricted epitopes of tumor-associated antigens in culture of mononuclear cells of breast cancer patients.

Authors:  Sergey Vital'evich Sennikov; Julia Alexandrovna Shevchenko; Vasilii Vasil'evich Kurilin; Julia Nikolaevna Khantakova; Julia Anatol'evna Lopatnikova; Elena Vasil'evna Gavrilova; Rinat Amirovich Maksyutov; Anastasiya Yur'evna Bakulina; Sergey Vasil'evich Sidorov; Alexander Alexandrovich Khristin; Amir Zakievich Maksyutov
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.